These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7437263)

  • 1. Pharmacokinetics of intravenous and oral prednisolone.
    Al-Habet S; Rogers HJ
    Br J Clin Pharmacol; 1980 Nov; 10(5):503-8. PubMed ID: 7437263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of fluocortolone and prednisolone after intravenous and oral administration.
    Täuber U; Haack D; Nieuweboer B; Kloss G; Vecsei P; Wendt H
    Int J Clin Pharmacol Ther Toxicol; 1984 Jan; 22(1):48-55. PubMed ID: 6698661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of prednisolone in normal and asthmatic subjects in relation to dose.
    McAllister WA; Winfield CR; Collins JV
    Eur J Clin Pharmacol; 1981; 20(2):141-5. PubMed ID: 7262175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of prednisolone after high doses of prednisolone hemisuccinate.
    Derendorf H; Rohdewald P; Möllmann H; Rehder J; Barth J; Neveling D
    Biopharm Drug Dispos; 1985; 6(4):423-32. PubMed ID: 4084667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose dependent pharmacokinetics of prednisone and prednisolone in man.
    Rose JQ; Yurchak AM; Jusko WJ
    J Pharmacokinet Biopharm; 1981 Aug; 9(4):389-417. PubMed ID: 7310640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
    Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
    Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary excretion of prednisolone following intravenous administration in humans.
    al-Habet SM; Rogers HJ
    J Clin Pharmacol; 1989 Oct; 29(10):922-7. PubMed ID: 2592584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prednisolone bioavailability in the dog.
    Tse FL; Welling PG
    J Pharm Sci; 1977 Dec; 66(12):1751-4. PubMed ID: 925942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in prednisolone disposition as a result of oral contraceptive use and dose.
    Meffin PJ; Wing LM; Sallustio BC; Brooks PM
    Br J Clin Pharmacol; 1984 Jun; 17(6):655-64. PubMed ID: 6743464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of prednisolone and endogenous cortisol suppression in the elderly.
    Stuck AE; Frey BM; Frey FJ
    Clin Pharmacol Ther; 1988 Apr; 43(4):354-62. PubMed ID: 3356080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia.
    Petersen KB; Jusko WJ; Rasmussen M; Schmiegelow K
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):465-73. PubMed ID: 12698270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of prednisolone on the pharmacokinetics of loratadine after oral and intravenous administration of loratadine in rats.
    Li C; Kim M; Choi JS
    Arch Pharm Res; 2010 Sep; 33(9):1395-400. PubMed ID: 20945138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent pharmacokinetics of prednisolone in normal and adrenalectomized rats.
    Boudinot FD; Jusko WJ
    J Pharmacokinet Biopharm; 1986 Oct; 14(5):453-67. PubMed ID: 3806371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of prednisolone after intravenous and oral administration.
    Barth J; Damoiseaux M; Möllmann H; Brandis KH; Hochhaus G; Derendorf H
    Int J Clin Pharmacol Ther Toxicol; 1992 Sep; 30(9):317-24. PubMed ID: 1428295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The absence of effect of azathioprine on prednisolone pharmacokinetics following maintenance prednisone doses in kidney transplant patients.
    Gambertoglio JG; Holford HG; Lizak PS; Birnbaum JL; Salvatierra O; Amend WJ
    Am J Kidney Dis; 1984 May; 3(6):425-9. PubMed ID: 6372445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and protein binding of prednisolone after oral and intravenous administration.
    Bergrem H; Grøttum P; Rugstad HE
    Eur J Clin Pharmacol; 1983; 24(3):415-9. PubMed ID: 6861855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability and reversible metabolism of prednisone and prednisolone in man.
    Garg V; Jusko WJ
    Biopharm Drug Dispos; 1994 Mar; 15(2):163-72. PubMed ID: 8011967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of methylprednisolone and prednisolone after single and multiple oral administration.
    Rohatagi S; Barth J; Möllmann H; Hochhaus G; Soldner A; Möllmann C; Derendorf H
    J Clin Pharmacol; 1997 Oct; 37(10):916-25. PubMed ID: 9505983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylprednisolone pharmacokinetics after intravenous and oral administration.
    Al-Habet SM; Rogers HJ
    Br J Clin Pharmacol; 1989 Mar; 27(3):285-90. PubMed ID: 2655680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylprednisolone versus prednisolone pharmacokinetics in relation to dose in adults.
    Szefler SJ; Ebling WF; Georgitis JW; Jusko WJ
    Eur J Clin Pharmacol; 1986; 30(3):323-9. PubMed ID: 3732369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.